We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ELISA:OMXHEXElisa Oyj Class A Analysis

Data as of 2026-03-11 - not real-time

€43.38

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Elisa Oyj trades at €43.38, roughly double the DCF‑derived fair value of €21.5, yielding a negative upside of about 3.3% and indicating significant overvaluation. The stock’s PE of 20.4 sits above the industry average of 18.1, while a dividend yield of 5.5% is offset by an unsustainable payout ratio of 110%, raising concerns about future cash flow coverage. Technicals show the price modestly above the 20‑day SMA (43.05) and 50‑day SMA (40.10), but the MACD has turned bearish and the RSI at 63% signals overbought conditions, suggesting limited near‑term upside.
Volatility is elevated at 20% over the past 30 days, yet beta is very low, indicating low systematic risk, while the company faces medium sector and regulatory risks inherent to the telecom industry. With modest revenue growth of 1.5% and a high debt‑to‑equity ratio exceeding 130%, the fundamentals do not justify the current premium, making the stock more attractive for income‑focused investors only if dividend sustainability improves.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above short‑term support at €42.06
  • Bearish MACD histogram indicating weakening momentum
  • RSI in overbought territory (63%) limiting upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Valuation gap versus DCF fair value suggests overpricing
  • Dividend payout exceeds 100% of earnings, questioning sustainability
  • Stable volume but modest 1.5% revenue growth limits upside

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Limited growth prospects in a mature Finnish telecom market
  • High debt‑to‑equity ratio (~135%) could pressure cash flows
  • Competitive and regulatory pressures may erode margins over time

Key Metrics & Analysis

Financial Health

Revenue Growth1.50%
Profit Margin15.15%
P/E Ratio20.4
ROE26.79%
ROA8.42%
Debt/Equity134.87
P/B Ratio5.6
Op. Cash Flow€688.6M
Free Cash Flow€334.6M
Industry P/E18.1

Technical Analysis

TrendNeutral
RSI63.3
Support€42.06
Resistance€44.10
MA 20€43.05
MA 50€40.10
MA 200€42.64
MACDBearish
VolumeStable
Fear & Greed Index75.45

Valuation

Fair Value€21.50
Target Price€41.96
Upside/Downside-3.28%
GradeOvervalued
TypeValue
Dividend Yield5.52%

Risk Assessment

Beta0.07
Volatility20.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.